147 related articles for article (PubMed ID: 19007313)
1. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
[TBL] [Abstract][Full Text] [Related]
3. Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis.
Rindi LV; Zaçe D; Braccialarghe N; Massa B; Barchi V; Iannazzo R; Fato I; De Maria F; Kontogiannis D; Malagnino V; Sarmati L; Iannetta M
Drug Saf; 2024 Apr; 47(4):333-354. PubMed ID: 38321317
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy.
Kim J; Kim C; Lee JA; Lee SJ; Lee KH; Kim JH; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
Sci Rep; 2023 Aug; 13(1):14291. PubMed ID: 37652945
[TBL] [Abstract][Full Text] [Related]
5. No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus Cohort.
Secher S; Hentzien M; Cuzin L; Jacomet C; Hocqueloux L; Rey D; Menard A; Arvieux C; Raffi F; Bani-Sadr F
AIDS Res Hum Retroviruses; 2024 Apr; 40(4):253-256. PubMed ID: 37756371
[TBL] [Abstract][Full Text] [Related]
6. Study of clinical profile and outcomes in progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome patients in the highly active antiretroviral therapy era - An observational study.
Arora S; Ahmad FMH; Deshwal R; Behal P
Indian J Sex Transm Dis AIDS; 2022; 43(2):156-160. PubMed ID: 36743095
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes.
Bakal JA; Charlton CL; Hlavay B; Jansen GH; Svenson LW; Power C
J Neurovirol; 2021 Jun; 27(3):476-481. PubMed ID: 33978904
[TBL] [Abstract][Full Text] [Related]
8. The Prognosis of Progressive Multifocal Leukoencephalopathy in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment: A Systematic Review.
Aye SL; Trivedi Y; Bolgarina Z; Desai HN; Senaratne M; Swami SS; Mohammed L
Cureus; 2023 Sep; 15(9):e45155. PubMed ID: 37842471
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital.
Ligero-López J; Sánchez-Castellano MÁ; Falces-Romero I; Montero-Vega MD; García-Rodríguez J
J Neurovirol; 2023 Oct; 29(5):598-604. PubMed ID: 37470903
[TBL] [Abstract][Full Text] [Related]
10. Acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome: prevalence, main characteristics, and outcomes in a Brazilian center.
Santana MN; Ferrari R; Macedo AC; Marcusso RMN; Fernandes RA; Vidal JE
Arq Neuropsiquiatr; 2023 Oct; 81(10):883-890. PubMed ID: 37899047
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
McEntire CRS; Fletcher A; Toledano M; Epstein S; White E; Tan CS; Mao-Draayer Y; Banks SA; Aksamit AJ; Gelfand JM; Thakur KT; Anand P; Cortese I; Bhattacharyya S
JAMA Neurol; 2023 Jun; 80(6):624-633. PubMed ID: 37093609
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: A retrospective analysis of a nationwide inpatient database.
Otaka H; Imai S; Fushimi K
J Neurol Sci; 2023 Oct; 453():120774. PubMed ID: 37651882
[TBL] [Abstract][Full Text] [Related]
13. Isolated pontocerebellar leukoencephalopathy in HIV-related PML: focus on the "shrimp sign".
Cimmino AT; Carlomagno V; Sciarrone MA; Di Lazzaro G; Silvestri G
Neurol Sci; 2024 Mar; 45(3):1295-1298. PubMed ID: 37870644
[No Abstract] [Full Text] [Related]
14. Clinical profile of central nervous system space-occupying lesions and their association with CD4 counts in patients with HIV: A prospective observational study.
Sawardekar VM; Sawadh RK; Sawardekar V; Singh B; Wankhade B
J Family Med Prim Care; 2024 Mar; 13(3):952-957. PubMed ID: 38736804
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
16. Incidence of progressive multifocal leukoencephalopathy in patients without HIV.
Amend KL; Turnbull B; Foskett N; Napalkov P; Kurth T; Seeger J
Neurology; 2010 Oct; 75(15):1326-32. PubMed ID: 20938025
[TBL] [Abstract][Full Text] [Related]
17. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.
Berger JR; Aksamit AJ; Clifford DB; Davis L; Koralnik IJ; Sejvar JJ; Bartt R; Major EO; Nath A
Neurology; 2013 Apr; 80(15):1430-8. PubMed ID: 23568998
[TBL] [Abstract][Full Text] [Related]
18. Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
Schwab N; Schneider-Hohendorf T; Melzer N; Cutter G; Wiendl H
Neurology; 2017 Mar; 88(12):1197-1205. PubMed ID: 28228564
[TBL] [Abstract][Full Text] [Related]
19. Progressive Multifocal Leukoencephalopathy.
Adang L; Berger J
F1000Res; 2015; 4():. PubMed ID: 26918152
[TBL] [Abstract][Full Text] [Related]
20. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes.
Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P
J Neurovirol; 2013 Aug; 19(4):351-8. PubMed ID: 23733308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
